Company / Inventory
Sonoma Pharmaceuticals, Inc. Inventory History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$2.9M
FY2025
5-year range
$2.7M / $2.9M
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory has fluctuated over the past 9 years, ranging from $2M in FY2020 to $3M in FY2019.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +5.9%.
Remained stable around $3M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +5.9%, indicating consistent growth.
- In FY2025, inventory increased 7.2% year-over-year.
- Peak inventory was recorded in FY2019.
- Lowest inventory in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $2.9M | +7.2% |
| FY2024 | $2.7M | -4.9% |
| FY2023 | $2.9M | +7.3% |
| FY2022 | $2.7M | +5.3% |
| FY2021 | $2.5M | +15.4% |
| FY2020 | $2.2M | -35.7% |
| FY2019 | $3.4M | +19.0% |
| FY2018 | $2.9M | +29.0% |
| FY2017 | $2.2M | +35.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026